The Problem:
Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells in particular are the generals of the immune system, directing and dictating immune responses. So it comes as no surprise that data has shown that dendritic cells are often dysfunctional in cancer patients.
Guardian Bio's Solution:
At Guardian Bio, our approach is focused on creating a personalized cell therapy based on dendritic cells. Our product drives anti-tumor activity through eliciting a diverse yet targeted immune response - mobilizing the entire army for the fight. We take stem cells from patients and turn them into cancer-targeted dendritic cells. Injecting our product back into patients will revitalize their immune system and give it the help it needs to win.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology
- Website
- http://www.guardian-bio.com
- Keywords
- Cambridge.
Guardian Bio Questions
Guardian Bio's website is http://www.guardian-bio.com
Guardian Bio's LinkedIn profile is https://www.linkedin.com/company/guardian-bio
Guardian Bio has
3 employees.
View email and phone details for 3
employees at Guardian Bio.
Guardian Bio's industry is
Biotechnology
Guardian Bio's top competitors are
Kano Therapeutics,
Cellino,
Surgicure Technologies, Inc.,
Davinci Wearables,
Nucleate,
Torpedo Therapeutics,
Ursure, Inc.,
Collage Venture Partners,
Petri,
Promakhos Therapeutics.
Guardian Bio's categories are Biotechnology
Guardian Bio's founding year is 2022
